Report overview
The global Vertebroplasty Bone Cement market size was valued at US$ 892.4 million in 2024 and is projected to reach US$ 1.45 billion by 2030, at a CAGR of 8.4% during the forecast period 2024-2030.
The United States Vertebroplasty Bone Cement market size was valued at US$ 289.5 million in 2024 and is projected to reach US$ 456.7 million by 2030, at a CAGR of 7.9% during the forecast period 2024-2030.
Vertebroplasty Bone Cement is a specialized acrylic cement used in vertebral compression fracture treatment.
The global market is growing rapidly, driven by aging population and minimally invasive procedures. In 2023, procedure volume reached 850,000 globally, with osteoporosis treatment accounting for 65% of usage. The market saw a 35% increase in radio-opaque cement adoption in 2023. PMMA-based cements dominate with an 80% market share, while bioactive cements are growing at 15% annually. North America leads with a 40% market share, while Asia Pacific is the fastest-growing region at 9.0% CAGR. The industry is focusing on developing enhanced visualization properties, with a 45% growth in R&D investments for procedure optimization.
Report Overview
Vertebroplasty Bone Cement refers to a medical-grade acrylic cement used in vertebroplasty procedures to stabilize fractured vertebrae and relieve pain caused by compression fractures.
This report provides a deep insight into the global Vertebroplasty Bone Cement market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vertebroplasty Bone Cement Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vertebroplasty Bone Cement market in any manner.
Global Vertebroplasty Bone Cement Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Stryker
Johnson & Johnson
Heraeus Medical
Smith & Nephew
B. Braun Melsungen AG
Medtronic
Alphatec Spine
DJO Global
Tecres
Osseon
Somatex Medical Technologies
Medacta International
Cook Medical
TEKNIMED
G-21
TSMRI
Market Segmentation (by Type)
Low Viscosity Cements
Medium Viscosity Cements
High Viscosity Vements
Market Segmentation (by Application)
Antibacterial
Non-antibacterial
Geographic Segmentation
